Luye Pharma Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BMG570071099
HKD
2.94
0.06 (2.08%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'12
Mar'12
Dec'11
Sep'11
Jun'11
Mar'11
Dec'10
Net Sales
617.00
641.65
625.32
575.12
502.05
437.90
370.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
617.00
641.65
625.32
575.12
502.05
437.90
370.90
Raw Material Cost
98.34
99.03
146.19
102.55
69.08
68.94
84.73
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.51
10.89
3.64
9.76
5.09
4.76
3.79
Selling and Distribution Expenses
390.09
417.37
387.65
350.50
324.00
279.94
250.83
Other Expenses
3.47
3.30
2.22
3.76
3.41
2.92
2.35
Total Expenditure (Excl Depreciation)
535.60
560.24
559.72
500.45
432.22
382.80
362.87
Operating Profit (PBDIT) excl Other Income
81.4
81.4
65.6
74.7
69.80000000000001
55.099999999999994
8
Other Income
2.00
-1.07
19.48
4.80
-3.91
4.84
-9.05
Operating Profit (PBDIT)
106.27
110.23
90.22
101.85
80.81
87.16
16.67
Interest
12.51
10.89
3.64
9.76
5.09
4.76
3.79
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
35.39
Gross Profit (PBDT)
518.65
542.63
479.13
472.57
432.97
368.96
286.17
Depreciation
25.29
31.42
27.83
23.22
16.34
27.71
38.37
Profit Before Tax
68.47
67.92
58.75
68.87
59.38
54.70
9.90
Tax
7.14
15.35
-8.39
16.16
17.63
16.23
0.77
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
57.69
49.88
66.32
47.94
36.54
32.42
5.03
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
57.69
49.88
66.32
47.94
36.54
32.42
5.03
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.90
3.35
0.85
4.95
5.44
6.25
5.44
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
61.59
53.23
67.17
52.89
41.98
38.67
10.47
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.16
0.16
Reserves
1,662.55
1,622.84
1,576.00
1,482.83
1,426.75
1,366.73
1,328.83
Earnings per share (EPS)
0.02
0.01
0.02
0.01
0.01
0.01
0.0
Diluted Earnings per share
0.02
0.01
0.02
0.01
0.01
0.01
0.0
Operating Profit Margin (Excl OI)
12.8%
12.45%
6.86%
12.84%
13.62%
12.47%
-3.41%
Gross Profit Margin
15.2%
15.48%
13.85%
16.01%
15.08%
18.82%
13.01%
PAT Margin
9.35%
7.77%
10.61%
8.34%
7.28%
7.4%
1.36%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2012 is 22.91% vs 28.32% in Jun 2011

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2012 is 46.67% vs -30.23% in Jun 2011

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2012 is 23.14% vs -1.51% in Jun 2011

stock-summary

Interest

YoY Growth in quarter ended Jun 2012 is 145.10% vs 30.77% in Jun 2011

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2012 has fallen from Jun 2011

Compare Quarterly Results Of Luye Pharma Group Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
617.00
0
617.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
617.00
0
617.00
Raw Material Cost
98.34
0
98.34
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
12.51
0
12.51
Selling and Distribution Expenses
390.09
0
390.09
Other Expenses
3.47
0.00
3.47
Total Expenditure (Excl Depreciation)
535.60
0
535.60
Operating Profit (PBDIT) excl Other Income
81.40
0.00
81.40
Other Income
2.00
0
2.00
Operating Profit (PBDIT)
106.27
0
106.27
Interest
12.51
0
12.51
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
518.65
0
518.65
Depreciation
25.29
0
25.29
Profit Before Tax
68.47
0
68.47
Tax
7.14
0
7.14
Provisions and contingencies
0.00
0
0.00
Profit After Tax
57.69
0
57.69
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
57.69
0
57.69
Share in Profit of Associates
0.00
0
0.00
Minority Interest
3.90
0
3.90
Other related items
0.00
0.00
0.00
Consolidated Net Profit
61.59
0
61.59
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
1,662.55
0
1,662.55
Earnings per share (EPS)
0.02
0
0.02
Diluted Earnings per share
0.02
0
0.02
Operating Profit Margin (Excl OI)
12.80%
0%
0.00
12.80%
Gross Profit Margin
15.20%
0%
0.00
15.20%
PAT Margin
9.35%
0%
0.00
9.35%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 61.70 Million
in Jun 2012

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2012 is -3.85% vs 2.62% in Mar 2012

stock-summary

YoY Growth in quarter ended Jun 2012 is 22.91% vs 28.32% in Jun 2011

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.16 Million
in Jun 2012

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2012 is 15.79% vs -20.83% in Mar 2012

stock-summary

YoY Growth in quarter ended Jun 2012 is 46.67% vs -30.23% in Jun 2011

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.43 Million
in Jun 2012

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2012 is -6.29% vs 57.43% in Mar 2012

stock-summary

YoY Growth in quarter ended Jun 2012 is 23.14% vs -1.51% in Jun 2011

Quarterly - Interest
Interest 1.25 Million
in Jun 2012

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2012 is 14.68% vs 202.78% in Mar 2012

stock-summary

YoY Growth in quarter ended Jun 2012 is 145.10% vs 30.77% in Jun 2011

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.80%
in Jun 2012

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2012 has improved from Mar 2012

stock-summary

YoY Growth in quarter ended Jun 2012 has fallen from Jun 2011